08/06/2026
I'm looking forward to joining colleagues from across the region at IMCAS Asia 2026.
This year, I'll be participating in a panel discussion on injectable complications, as well as a session exploring some of the current controversies surrounding the extracellular matrix (ECM), an area that continues to generate important discussion and research within aesthetic medicine.
I'm also pleased to be presenting at the Merz Symposium and contributing to the ongoing conversation around evidence-based approaches, innovation, and patient outcomes.
IMCAS provides a valuable opportunity to share knowledge, challenge perspectives, and connect with experts dedicated to advancing our field.
If you're attending IMCAS Asia 2026, I'd love to connect and continue the conversation.